Reviva pharmaceuticals joins webull corporate communications service platform

Cupertino, calif., may 19, 2023 (globe newswire) -- reviva pharmaceuticals holdings, inc. (nasdaq: rvph) (“reviva” or the “company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (cns), respiratory and metabolic diseases, today announced the company has joined webull's corporate communications service platform. the reviva portal on the webull platform will help provide the company with a direct line of communication with its shareholders and provide reviva followers with instant notifications regarding corporate content like company news, earnings reports, investor presentations, and more.
RVPH Ratings Summary
RVPH Quant Ranking